Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have had 2 or fewer prior lines of treatment for their condition (confirm with trial site)
- People who are willing to sign a consent form agreeing to take part in the study
- People who have been diagnosed with skin melanoma, confirmed by a laboratory test on a tissue or cell sample
- People whose tumor has been tested and found to have a specific gene change called BRAF V600E
- People whose treating doctor has determined them to be eligible for a type of targeted therapy (called BRAFi/MEKi) or immunotherapy, either to reduce the risk of cancer returning after surgery or for more advanced disease (typically classified as stage III or IV, high risk)
Who may not be able to join:
- People whose life expectancy is estimated to be less than 8 weeks
- People who have other health conditions that would make regular blood draws difficult or unsafe, as determined by their doctor
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 06 5266 2533
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pilot study, descriptive statistics will be adopted (frequency, average, standard deviation, median, interval). Concordance indexes will be calculated, e.g. between dPCR and ELISA assays on the one hand and Versilib data on the other.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.